Home / Late quarterly reports / Shuttle Pharmaceuticals Holdings, Inc.
Filed 2026-08-17 路 Form NT 10-Q 路 Accession 0001493152-26-038790 nano
Price before filing: $4.07 (2026-08-14 close, split/dividend-adjusted)
Market cap at flag: $2.1M (2026-08-17) 路 Latest: $5.2M (2026-10-16)
| Window | SHPH | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -23.1% | -2.9% | -20.2% | 2026-09-16 |
| 90 days | pending | pending | until 2026-11-15 | |
| 180 days | pending | pending | until 2027-02-13 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider sold $505K (5 sales); 1 insider bought $182K (6 purchases)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-29 | HRT FINANCIAL LP 10% owner | Purchase | 25,836 | $3.44 | $89K | no | Form 4 |
| 2026-06-30 | HRT FINANCIAL LP 10% owner | Purchase | 6,755 | $3.23 | $22K | no | Form 4 |
| 2026-07-01 | HRT FINANCIAL LP 10% owner | Purchase | 3,959 | $3.30 | $13K | no | Form 4 |
| 2026-07-02 | HRT FINANCIAL LP 10% owner | Purchase | 7,851 | $3.54 | $28K | no | Form 4 |
| 2026-07-06 | HRT FINANCIAL LP 10% owner | Sale | 9,022 | $3.51 | $32K | no | Form 4 |
| 2026-07-07 | HRT FINANCIAL LP 10% owner | Sale | 10,580 | $3.33 | $35K | no | Form 4 |
| 2026-07-08 | HRT FINANCIAL LP 10% owner | Sale | 18,531 | $3.52 | $65K | no | Form 4 |
| 2026-07-09 | HRT FINANCIAL LP 10% owner | Purchase | 8,266 | $3.38 | $28K | no | Form 4 |
| 2026-07-10 | HRT FINANCIAL LP 10% owner | Purchase | 731 | $3.11 | $2K | no | Form 4 |
| 2026-07-13 | HRT FINANCIAL LP 10% owner | Sale | 1,033 | $4.67 | $5K | no | Form 4 |
| 2026-07-14 | HRT FINANCIAL LP 10% owner | Sale | 82,116 | $4.48 | $368K | no | Form 4 |
| 2026-08-17: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-05-19 to 2026-09-16. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
The company told the SEC it could not file its quarterly report on time (Form NT 10-Q) and then missed the 5-day extension too. Repeated late filings are a stronger warning.
Status: filed late (report filed 2026-09-24)
Why this score: filed late on 2026-09-24; also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.